Citigroup
C
Bank of America
BAC
Apple
AAPL
American Express
AXP
Chevron
CVX
US Stock MarketDetailed Quotes
VTGN VistaGen Therapeutics
- 2.9700
- +0.1200+4.21%
Close Feb 14 16:00 ET
- 2.8654
- -0.1046-3.52%
Post 20:01 ET
85.72MMarket Cap-2.01P/E (TTM)
3.1000High2.7834Low265.80KVolume2.9500Open2.8500Pre Close795.41KTurnover1.39%Turnover RatioLossP/E (Static)28.86MShares5.740052wk High1.06P/B56.94MFloat Cap2.220052wk Low--Dividend TTM19.17MShs Float1889.9991Historical High--Div YieldTTM11.11%Amplitude1.6200Historical Low2.9920Avg Price1Lot Size
VistaGen Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -116.56%-10.28M | -75.86%-10.89M | -37.74%-10.87M | 48.08%-25.81M | 6.54%-6.99M | 52.21%-4.75M | 62.12%-6.19M | 50.58%-7.89M | -9.85%-49.72M | 52.06%-7.47M |
| Net income from continuing operations | -121.87%-14.09M | -96.74%-12.96M | -55.48%-10.73M | 50.44%-29.36M | 22.13%-9.52M | 34.95%-6.35M | 62.32%-6.59M | 65.09%-6.9M | -24.05%-59.25M | 26.73%-12.23M |
| Operating gains losses | ---- | ---- | ---- | -92.31%6K | ---- | ---- | ---- | ---- | --78K | --600 |
| Depreciation and amortization | 12.59%161K | 12.95%157K | 8.63%151K | 6.77%568K | 6.60%147K | 8.17%143K | 4.83%139K | 7.50%139K | -25.19%532K | 3.37%137.9K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.56M | ---- |
| Change In working capital | 180.17%2.67M | 391.08%946K | 15.80%-1.43M | -60.88%793K | 308.92%1.86M | 184.49%953K | -1,384.02%-325K | -162.31%-1.7M | 205.69%2.03M | 204.50%455.1K |
| -Change in prepaid assets | 1,236.78%989K | -79.07%104K | -365.38%-968K | -92.16%250K | -68.02%48K | -114.34%-87K | -62.65%497K | -118.90%-208K | 265.77%3.19M | -21.33%150.1K |
| -Change in payables and accrued expense | 635.32%1.98M | 367.33%1.2M | 62.49%-455K | 155.89%522K | 232.93%1.92M | 118.40%269K | 78.09%-450K | -160.44%-1.21M | -155.37%-934K | 217.83%575.5K |
| -Change in other current assets | ---- | ---- | --190K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in other current liabilities | 35.20%-81K | -63.33%-196K | -14.04%-130K | -14.32%-495K | -21.97%-136K | -14.16%-125K | -12.04%-120K | -8.67%-114K | 36.04%-433K | -8.57%-111.5K |
| -Change in other working capital | -124.11%-216K | 109.92%25K | 59.63%-65K | 150.49%516K | 120.75%33K | 650.71%896K | -131.16%-252K | 42.70%-161K | 120.51%206K | -351.70%-159K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -116.56%-10.28M | -75.86%-10.89M | -37.74%-10.87M | 48.08%-25.81M | 6.54%-6.99M | 52.21%-4.75M | 62.12%-6.19M | 50.58%-7.89M | -9.85%-49.72M | 52.06%-7.47M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,218.75%-422K | -7.79M | -5.47M | 91.76%-61K | 94.51%-29K | -156.00%-32K | 0 | 0 | -269.26%-740K | -527,900.00%-528K |
| Net PPE purchase and sale | --0 | ---61K | ---42K | 71.23%-61K | ---29K | -156.00%-32K | --0 | --0 | -5.79%-212K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---528K | ---- |
| Net investment purchase and sale | ---422K | ---7.73M | ---5.43M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,218.75%-422K | ---7.79M | ---5.47M | 91.76%-61K | 94.51%-29K | -156.00%-32K | --0 | --0 | -269.26%-740K | -527,900.00%-528K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.75%1.17M | 0 | -89.94%88K | 12,434.49%128.4M | 4.38%-380K | 30,922.43%93.73M | 10,332.34%34.18M | 16,009.09%875K | -109.93%-1.04M | -1,776.79%-397.4K |
| Net issuance payments of debt | --0 | --0 | --0 | 4.74%-985K | --0 | 100.32%1K | -154.70%-785K | -96.67%-201K | -34,366.67%-1.03M | -156,150.00%-312.5K |
| Net common stock issuance | -98.87%1.06M | -100.25%-88K | -91.82%88K | 184,927.14%129.38M | -349.29%-381K | --93.73M | 115,469.64%34.96M | 2,285.81%1.08M | -101.58%-70K | -129.99%-84.8K |
| Proceeds from stock option exercised by employees | 3,666.67%113K | ---- | ---- | -87.30%8K | 1,100.00%1K | -57.14%3K | ---- | ---- | -98.96%63K | 99.96%-100 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.75%1.17M | --0 | -89.94%88K | 12,434.49%128.4M | 4.38%-380K | 30,922.43%93.73M | 10,332.34%34.18M | 16,009.09%875K | -109.93%-1.04M | -1,776.79%-397.4K |
| Net cash flow | ||||||||||
| Beginning cash position | 124.01%84.25M | 969.61%102.92M | 616.23%119.17M | -75.58%16.64M | 405.49%126.56M | 6.58%37.61M | -81.49%9.62M | -75.58%16.64M | -33.92%68.14M | -70.09%25.04M |
| Current changes in cash | -110.71%-9.53M | -166.72%-18.67M | -131.58%-16.25M | 299.10%102.53M | 11.97%-7.39M | 967.83%88.95M | 267.59%27.99M | 56.55%-7.02M | -47.25%-51.5M | 46.04%-8.4M |
| End cash Position | -40.96%74.72M | 124.01%84.25M | 969.61%102.92M | 616.23%119.17M | 616.23%119.17M | 405.49%126.56M | 6.58%37.61M | -81.49%9.62M | -75.58%16.64M | -75.58%16.64M |
| Free cash flow | -115.11%-10.28M | -76.85%-10.95M | -38.27%-10.91M | 48.18%-25.87M | 6.15%-7.01M | 51.95%-4.78M | 62.18%-6.19M | 51.12%-7.89M | -9.84%-49.93M | 52.06%-7.47M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.